Adults with biopsy confirmed IgA nephropathy were more frequently treated with SGLT2 inhibitors and RAAS inhibitors (p < 0.001), whereas corticosteroids were administered in both pediatric and adult patients (Table 1). Here, SLC5A2 is linked to IgA glomerulonephritis.